Inspira Technologies OXY B.H.N. (IINN) to Release Quarterly Earnings on Wednesday

Inspira Technologies OXY B.H.N. (NASDAQ:IINN) will likely be releasing its resultson Wednesday, April 1st. Analysts expect Inspira Technologies OXY B.H.N. to post earnings of ($0.20) per share and revenue of $0.20 million for the quarter.

Inspira Technologies OXY B.H.N. Trading Down 3.1%

NASDAQ IINN opened at $0.55 on Wednesday. Inspira Technologies OXY B.H.N. has a 52 week low of $0.40 and a 52 week high of $1.65. The company has a quick ratio of 0.90, a current ratio of 1.15 and a debt-to-equity ratio of 0.27. The stock’s 50-day moving average price is $0.66 and its 200-day moving average price is $0.93.

Institutional Trading of Inspira Technologies OXY B.H.N.

A hedge fund recently bought a new stake in Inspira Technologies OXY B.H.N. stock. Kestra Advisory Services LLC purchased a new position in Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 78,824 shares of the company’s stock, valued at approximately $71,000. Institutional investors own 12.72% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Inspira Technologies OXY B.H.N. in a report on Monday, December 29th. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Inspira Technologies OXY B.H.N. has a consensus rating of “Hold” and a consensus target price of $2.00.

About Inspira Technologies OXY B.H.N.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.